Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clinical Trials Need Peer Review To Qualify For Medicare Funds - AHRQ Panel

Executive Summary

Clinical trials seeking Medicare reimbursement of routine care costs should first undergo an external scientific review, a multi-agency panel convened by the Agency for Healthcare Research & Quality said.

You may also be interested in...



Medicare Trial Coverage Should Be Limited To Multi-Center Studies - Oxford

Medicare should only cover clinical trial costs for multi-center studies, Oxford Health Plans Exec VP & Chief Medical Officer Alan Muney, MD, said.

Medicare Trial Coverage Should Be Limited To Multi-Center Studies - Oxford

Medicare should only cover clinical trial costs for multi-center studies, Oxford Health Plans Exec VP & Chief Medical Officer Alan Muney, MD, said.

Medicare Clinical Trial Coverage For IND-Exempt Trials Sought By PhRMA

PhRMA is urging the Health Care Financing Administration to include permanent automatic qualification for IND-exempt trials in its Medicare clinical trial coverage policy.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS037947

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel